施裕丰教授作为第一作者在Nature、Cell、Nature Immunology等顶级权威杂志上发表代表性论文多篇，这些工作分别有同行在Nature Review Drug
Discovery以及Nature Review Cancer、 Cell 、Nature Immunology等杂志进行亮点点评。施裕丰教授拥有1项国际发明专利，曾以共同主持人身份主持1项美国纪念斯隆-凯特琳癌症中心药物研究项目，参与2 项美国国家健康研究院（NIH）研究项目和3 项德克萨斯州肿瘤研究院项目。其工作成果曾获得全国百篇优秀论文、中国科学院百篇和谈家桢基金生命科学九源奖学金等一系列奖项。施裕丰教授亦是同济大学脑与脊髓研究中心“泰禾冠名教授“。
2019年8月加入同济大学后，获得上海市第九批海外高层次引进人才，以通讯或同通讯发表专业学术论文多篇。
1) Shi Y., Lim SK., Liang Q., Iyer S., Wang H., Wang Z., Xie X.,
Chen Y., Tabar V., Glutin P., Williams N., De Brabander JK., and Parada LF. A
novel oxidative phosphorylation inhibitor targets glioblastoma. Nature, 2019 Mar;
567(7748):341-346. 第一作者，文章在Nature Review Drug
Discovery 和Nature Review
Cancer 上被亮点点评。
2) Shi, Y., Feng, Y., Kang, J., Liu, C., Li, Z., Li, D., Cao, W., Bi,
E., Zang, L., Lu, C., Zhang, J., and Pei, G. Critical
regulation of CD4+ T cell survival and autoimmunity by beta-Arrestin 1. Nat
Immnol. 2007 8(8):817-824. 第一作者
3) Kang, J*., Shi, Y*., Xiang, B*., Qu, B., Su, W.,
Zhu, M., Zhang, M., Bao, G., Wang, F., Zhang, X., et al. A nuclear function of
beta-arrestin1 in GPCR signaling regulation of histone acetylation and gene
transcription. Cell 2005
123, 833-847.1. (*These authors contributed equally to this paper) 共同一作
4) Shi, Y., Lim, SK., Parada, LF. The soft
underbelly of tumor cells. Cell
research, 2014 24:910–911 第一作者
5) Shi, Y., Stefan, C., Emr, S. Two novel WD40 domain-containing
protein, Ere1 and Ere2, function in the retromer-mediated endosomal recycling
pathway. MBoC,
2011 Nov;22(21):4093-107. 第一作者
6) Zilai Wang, Daochun Sun, Yu-Jung Chen,
Xuanhua Xie, Yufeng Shi, Viviane
Tabar, Cameron W. Brennan Tejus Bale, Chenura D. Jayewichreme, Dan R. Laks,
Sheila Alcantara Llaguno and Parada LF. Cell lineage-Based Stratification for
glioblastoma. Cancer Cell, 2020 Sep;
7）Shichao Huang2#*,
Yu’e Liu1#, Yanan Zhang3#, Ru Zhang1, ChengJie Zhu1, Lihong Fan1 , Gang
Pei1,2, Bo Zhang3 *, Yufeng Shi * Baicalein
inhibits SARS-CoV-2/VSV replication with interfering mitochondrial
oxidative phosphorylation in a mPTP dependent manner，Signal
Transduction and Targeted Therapy, 2020 通讯作者
8）Yu’e Liu#, Yufeng Shi* Mitochondria as a target
in cancer treatment. Medcomm,2020.9.1
(2):129-139 通讯作者
9) Ming Li # , Bingjie Hao # , Menghuan Zhang # , Russel J Reiter , Shumeng Lin , Tiansheng Zheng , Xiangyun Chen , Yanbei Ren , Liduo Yue , Baigenzhin Abay , Guojie Chen , Xiao Xu 1, Yufeng Shi* , Lihong Fan* Melatonin
enhances radiofrequency-induced NK antitumor immunity, causing cancer
metabolism reprogramming and inhibition of multiple pulmonary tumor
development. Signal Transduction and
Targeted Therapy, 2021 doi:
10.1038/s41392-021-00745-7. 共同通讯作者
10）Yu’e Liu#, Chao
Chen#, Xinye Wang, Yihong Sun, Juxiang Chen*, Yufeng Shi*, An Epigenetic Role of Mitochondria in Cancer, Cells, 2022, 11(16), 2518; 通讯作者
11) Changqing Wu #1, Yu'e Liu #1, Wenju Liu# 2, Tianhui Zou# 3, Shaojuan Lu 1, Chengjie Zhu 1, Le He 1, Jie Chen 1, Lan Fang 1, Lin Zou 4, Ping Wang 1, Lihong Fan 5, Hongxiang Wang 6, Han You 7, Juxiang Chen* 6, Jing-Yuan Fang* 3, Cizhong Jiang *2, Yufeng Shi* 1 2 8 NNMT-DNMT1 Axis is
Essential for Maintaining Cancer Cell Sensitivity to Oxidative Phosphorylation
Inhibition Advanced Science 2022 DOI: 10.1002/advs.202202642 通讯作者
12) Yu’e Liu, Yufeng Shi,
Ping Wang*, Functions of glutaminyl cyclase and its isoform in diseases Visualized Cancer Medicine https://doi.org/10.1051/vcm/2022008 共同作者
13) Yu’e Liu#*,
Yihong Sun#, Xiaoyun Shi#, Xi Chen, Yi Wang, Yufeng Shi*, An Overview: The Diversified Role of Mitochondria in
Cancer Metabolism. International Journal of
Biological Sciences 2023 https://www.ijbs.com/v19p0897.htm 通讯作者
14) Yuanpei Li #, Xiaoniu He # ,Xiao Lu , Zhicheng Gong , Qing Li , Lei Zhang , Ronghui Yang , Chengyi Wu , Jialiang Huang , Jiancheng Ding , Yaohui He , Wen Liu , Ceshi Chen , Bin Cao , Dawang Zhou , Yufeng Shi , Juxiang Chen , Chuangui Wang, Shengping Zhang, WangJian Zhang , Jing Ye , Han You * METTL3
acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic
functions Nature Communications 2022 DOI: 10.1038/s41467-022-34209-5 共同作者
15）Jin-Zhu Wang 1, Hong Zhu 1, Pu You 2, Hui Liu 1, Wei-Kang Wang 1, Xiaojuan Fan 3, Yun Yang 3, Keren Xu 4, Yingfeng Zhu 5, Qunyi Li 6, Ping Wu 7, Chao Peng 7, Catherine Cl Wong 7, Kaicheng Li 2, Yufeng Shi 8, Nu Zhang 9, Xiuxing Wang 10, Rong Zeng 4, Ying Huang 11, Liusong Yang 12, Zefeng Wang 3, Jingyi Hui 1 Upregulated YB-1 protein promotes glioblastoma growth through a
YB-1/CCT4/mLST8/mTOR pathway The Journal
of Clinical Investigation 2022. DOI: 10.1172/JCI146536 共同作者
16）Yu'e Liu#, Yanjin Wang#, Yanrong Yang#,, Linjun Weng, Qi Wu,
Jin Zhang, Pengcheng Zhao, Lan Fang*, Yufeng
Shi*, Ping Wang* Emerging phagocytosis checkpoints in cancer immunotherapy. Signal Transduction and Targeted Therapy, 2023 Mar 7;8(1):104 共同通讯
17) Yu’e
Liu1#*, Shaojuan Lu1#, Yihong Sun1#, Fei Wang2,
Shibo Yu3, Xi Chen4, Lei-lei Wu5, Hui Yang6,7, Yufeng Shi8* ,Kaijun Zhao1* Deciphering the role of QPCTL in glioma
progression and cancer immunotherapy Frontiers in Immunology 2023 共同通讯
18）Chao Chen1#, Yu’e Liu2#,
Hongxiang Wang1, Xu Zhang1, Yufeng Shi2*, Juxiang Chen1* FOXO1-miR-506 axis
promotes chemosensitivity to temozolomide and suppresses invasiveness in
glioblastoma through a feedback loop of miR-506/ETS1/FOXO1 Journal of Zhejiang University-SCIENCE B 2023 共同通讯